newsfilter
← Latest News
Business Wire·

Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by